Trials / Completed
CompletedNCT00215397
Study in Patients With Asthma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 16 (planned)
- Sponsor
- Dey · Industry
- Sex
- All
- Age
- 5 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine which dose of the investigational drug is the most safe and effective in the treatment of asthma compared to the control drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Formoterol Fumarate |
Timeline
- Primary completion
- 2003-02-01
- Completion
- 2005-12-01
- First posted
- 2005-09-22
- Last updated
- 2010-11-11
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00215397. Inclusion in this directory is not an endorsement.